Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20091
20101
20131
20161
20171
20181
20193
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Eisai Co., Ltd.2
Pfizer2
Bayer1
Celgene1
Haruhiko Fukuda1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell13
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Non-Hodgkin6
Lymphoma, Follicular5
Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Mantle-Cell2
Recurrence2
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.